3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Leukemia, Myeloid, Acute
196
Myelodysplastic Syndromes
128
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Leukemia, Lymphocytic, Chronic, B-Cell
102
Leukemia
102
Lymphoma
86
Multiple Myeloma
81
Lymphoma, Non-Hodgkin
80
Hematologic Neoplasms
65
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
62
Hodgkin Disease
62
Recurrence
52
Lymphoma, B-Cell
40
Lymphoma, Mantle-Cell
39
Myeloproliferative Disorders
36
Lymphoma, Follicular
35
Melanoma
34
Lymphoma, Large B-Cell, Diffuse
31
Burkitt Lymphoma
31
Graft vs Host Disease
28
Neoplasms, Plasma Cell
24
Primary Myelofibrosis
23
Ovarian Neoplasms
23
Lymphoma, B-Cell, Marginal Zone
23
Anemia, Refractory, with Excess of Blasts
21
Leukemia, Myelomonocytic, Chronic
20
Leukemia, Biphenotypic, Acute
17
Lymphoma, T-Cell
16
Neuroblastoma
15
Neoplasms
14
Interventions
Lenalidomide
2
Dexamethasone
2
ixazomib
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Cyclophosphamide
1
Calcium Dobesilate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
POEMS Syndrome
×
fludarabine
×
Clear all
NCT04561557
2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1
Recruiting
36 enrolled